U.S. Government Gives Moderna $176 Million to Develop mRNA Bird Flu Biologic

On July 2, 2024, the U.S. government awarded a $176 million contract to Moderna, Inc. for the development of an mRNA H5N1 avian influenza biologic labeled a “vaccine”